Bevacizumab (B), cisplatin and vinorelbine in chemo-naive patients (P) with non squamous non small cell lung cancer (NSCLC): a galician lung cancer group phase II study

被引：0
|
作者：
Vazquez, S. [1 ]
Leon, L. [2 ]
Gracia, J. M. [3 ]
Casal, J. [4 ]
Lazaro, M. [5 ]
Firvida, J. L. [6 ]
Amenedo, M. [7 ]
Santome, L. [8 ]
Cardona, J. V. [9 ]
Macia, S. [10 ]
机构：
[1] Complexo Hosp Xeral Calde, Lugo, Spain
[2] Complexo Hosp Univ Santiago, Santiago De Compostela, Spain
[3] Hosp Cabuenes, Gijon, Spain
[4] Complexo Hosp Univ Vigo Hosp Do Meixoeiro, Vigo, Spain
[5] Complexo Hosp Univ Vigo Hosp Xeral Cies, Vigo, Spain
[6] Complexo Hosp Ourense, Orense, Spain
[7] Ctr Oncol Galicia, La Coruna, Spain
[8] Hosp POVISA, Vigo, Spain
[9] Roche Farma SA, Madrid, Spain
[10] Hosp Gen Elda, Elda, Spain
来源：
EJC SUPPLEMENTS | 2009年 / 7卷 / 02期
关键词：
D O I：
10.1016/S1359-6349(09)71858-0
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：548 / 549
页数：2
相关论文
共 50 条
  • [21] A phase I trial of afatinib and bevacizumab in chemo-naive patients with advanced non-small-cell lung cancer harboring EGFR mutations: Okayama Lung Cancer Study Group Trial 1404
    Ninomiya, Takashi
    Nogami, Naoyuki
    Kozuki, Toshiyuki
    Harada, Daijiro
    Kubo, Toshio
    Ohashi, Kadoaki
    Kuyama, Shoichi
    Kudo, Kenichiro
    Bessho, Akihiro
    Fukamatsu, Nobuaki
    Fujimoto, Nobukazu
    Aoe, Keisuke
    Shibayama, Takuo
    Sugimoto, Keisuke
    Takigawa, Nagio
    Hotta, Katsuyuki
    Kiura, Katsuyuki
    LUNG CANCER, 2018, 115 : 103 - 108
  • [22] A phase II randomized study of paclitaxel plus carboplatin or cisplatin against chemo-naive inoperable non-small cell lung cancer in the elderly
    Chen, Yuh-Min
    Perng, Reury-Perng
    Tsai, Chun-Ming
    Whang-Peng, Jacqueline
    JOURNAL OF THORACIC ONCOLOGY, 2006, 1 (02) : 141 - 145
  • [23] Phase II trial of oral vinorelbine in combination with cisplatin in advanced non small cell lung cancer (NSCLC)
    Garassino, I
    Campagnoli, E.
    Cavina, R.
    Soto, Parra H. J.
    De Vincenzo, F.
    Zucali, P. A.
    Salamina, S.
    Ceresoli, G. L.
    Santoro, A.
    ANNALS OF ONCOLOGY, 2006, 17 : XI20 - XI20
  • [24] A randomized phase II study of afatinib alone or combined with bevacizumab for treating chemo-naive patients with non-small cell lung cancer harboring EGFR mutations
    Ninomiya, Takashi
    Ishikawa, Nobuhisa
    Kozuki, Toshiyuki
    Kuyama, Shoichi
    Inoue, Koji
    Yokoyama, Toshihide
    Kanaji, Nobuhiro
    Yasugi, Masayuki
    Shibayama, Takuo
    Aoe, Keisuke
    Ochi, Nobuaki
    Fujitaka, Kazunori
    Kodani, Masahiro
    Ueda, Yutaka
    Watanabe, Kazuhiko
    Bessho, Akihiro
    Sugimoto, Keisuke
    Oze, Isao
    Hotta, Katsuyuki
    Kiura, Katsuyuki
    LUNG CANCER, 2023, 184
  • [25] Phase II trial of oral vinorelbine in combination with cisplatin in advanced non small cell lung cancer (NSCLC)
    Campagnoli, E.
    Garassino, I.
    Cavina, R.
    Parra, H. J. Soto
    De Vincenzo, F.
    Zucali, P. A.
    Salamina, S.
    Ceresoli, G. L.
    Santoro, A.
    LUNG CANCER, 2006, 52 : S20 - S20
  • [26] Phase II trial of oral vinorelbine in combination with cisplatin in advanced non small cell lung cancer (NSCLC)
    Campagnoli, E.
    Garassino, I.
    Cavina, R.
    Parra, H. J. Soto
    De Vincenzo, F.
    Zucali, P. A.
    Salamina, S.
    Ceresoli, G. L.
    Santoro, A.
    PROCEEDINGS OF THE 10TH CENTRAL EUROPEAN LUNG CANCER CONFERENCE, 2006, : 29 - +
  • [27] Apatinib in combination with pemetrexed-platinum chemotherapy for chemo-naive non-squamous non-small cell lung cancer: a phase II clinical study
    Yang, Guangjian
    Xu, Haiyan
    Yang, Lu
    Xu, Fei
    Zhang, Shuyang
    Yang, Yaning
    Wang, Yan
    LUNG CANCER, 2020, 147 : 229 - 236
  • [28] A phase II study with cisplatin and vinorelbine in elderly patients with advanced Non-Small Cell Lung Cancer
    Lucio, Buffoni
    Davide, Ottaviani
    Alfredo, Addeo
    Vincenzo, Dongiovanni
    Raffaella, Grillo
    Camilla, Fissore
    Carla, Barone
    Diego, Dongiovanni
    Erika, Larovere
    Oscar, Bertetto
    ANNALS OF ONCOLOGY, 2005, 16 : 27 - 27
  • [29] A phase II study of weekly irinotecan plus capecitabine for chemo-naive patients with advanced non-small cell lung cancer.
    Kim, HT
    Han, JY
    Lee, DH
    Lee, SY
    Park, CG
    Kim, HY
    Lee, HG
    Lee, JJ
    Lee, JS
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 653S - 653S
  • [30] Phase II trial of carboplatin and pemetrexed combination in elderly patients with advanced non-squamous non small cell lung cancer (NS-NSCLC). A Galician Lung Cancer Group Study.
    Areses Manrique, Ma Carmen
    Fernandez Nunez, Natalia
    Covela Rua, Marta
    Alonso Herrero, Ana
    Villanueva Silva, Maria Jose
    Afonso Afonso, Francisco J.
    Esquerdo, Gaspar
    Campos Balea, Begona
    Lazaro Quintela, Martin
    Garcia Mata, Jesus
    Vazquez-Estevez, Sergio
    Anido Herranz, Urbano
    Casal Rubio, Joaquin
    Firvida Perez, Jose Luis
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
12345